Development and Evaluation of Nomograms to Predict the Cancer-Specific Mortality and Overall Mortality of Patients with Hepatocellular Carcinoma

doi:10.1155/2021/1658403

科研成果详情

题名	Development and Evaluation of Nomograms to Predict the Cancer-Specific Mortality and Overall Mortality of Patients with Hepatocellular Carcinoma
作者	Ni, Xiaofeng1,2; Li, Ding2; Dai, Shengjie1; Pan, Hao3; Sun, Hongwei1; Ao, Jianyang1; Chen, Lei 1,3; Kong, Hongru1,2
发表日期	2021-03-30
发表期刊	BIOMED RESEARCH INTERNATIONAL 影响因子和分区
语种	英语
原始文献类型	Article
摘要	Hepatocellular carcinoma (HCC) is the most common type among primary liver cancers (PLC). With its poor prognosis and survival rate, it is necessary for HCC patients to have a long-term follow-up. We believe that there are currently no relevant reports or literature about nomograms for predicting the cancer-specific mortality of HCC patients. Therefore, the primary goal of this study was to develop and evaluate nomograms to predict cancer-specific mortality and overall mortality. Data of 45,158 cases of HCC patients were collected from the Surveillance, Epidemiology, and End Results (SEER) program database between 2004 and 2013, which were then utilized to develop the nomograms. Finally, the performance of the nomograms was evaluated by the concordance index (C-index) and the area under the time-dependent receiver operating characteristic (ROC) curve (td-AUC). The categories selected to develop a nomogram for predicting cancer-specific mortality included marriage, insurance, radiotherapy, surgery, distant metastasis, lymphatic metastasis, tumor size, grade, sex, and the American Joint Committee on Cancer (AJCC) stage; while the marriage, radiotherapy, surgery, AJCC stage, grade, race, sex, and age were selected to develop a nomogram for predicting overall mortality. The C-indices for predicted 1-, 3-, and 5-year cancer-specific mortality were 0.792, 0.776, and 0.774; the AUC values for 1-, 3-, and 5-year cancer-specific mortality were 0.830, 0.830, and 0.830. The C-indices for predicted 1-, 3-, and 5-year overall mortality were 0.770, 0.755, and 0.752; AUC values for predicted 1-, 3-, and 5-year overall mortality were 0.820, 0.820, and 0.830. The results showed that the nomograms possessed good agreement compared with the observed outcomes. It could provide clinicians with a personalized predicted risk of death information to evaluate the potential changes of the disease-specific condition so that clinicians can adjust therapy options when combined with the actual condition of the patient, which is beneficial to patients.
资助项目	Youth Foundation of National Natural Science Foundation of China [81700568]; Zhejiang Medical and Health Science and Technology Plan Project [2019RC210]; Natural Science Foundation of Zhejiang ProvinceNatural Science Foundation of Zhejiang Province [LY17H160057]
出版者	HINDAWI LTD
出版地	LONDON
ISSN	2314-6133
EISSN	2314-6141
卷号	2021 页码:1658403
DOI	10.1155/2021/1658403
页数	12
WOS类目	Biotechnology & Applied Microbiology ; Medicine, Research & Experimental
WOS研究方向	Biotechnology & Applied Microbiology ; Research & Experimental Medicine
WOS记录号	WOS:000640307900009
收录类别	SCIE ; PUBMED ; SCOPUS
URL	查看原文
PubMed ID	33860031
PMC记录号	PMC8024067
SCOPUSEID	2-s2.0-85104459621
通讯作者地址	[Chen, Lei]Department of Surgery,The First Affiliated Hospital of Wenzhou Medical University,Wenzhou, Zhejiang Province,China ; [Kong, Hongru]Department of Surgery,The First Affiliated Hospital of Wenzhou Medical University,Wenzhou, Zhejiang Province,China
Scopus学科分类	Immunology and Microbiology (all);Biochemistry, Genetics and Molecular Biology (all)
引用统计	被引频次：5[WOS] [WOS记录] [WOS相关记录]
文献类型	期刊论文
条目标识符	https://kms.wmu.edu.cn/handle/3ETUA0LF/12038
专题	第一临床医学院（信息与工程学院）、附属第一医院附属第一医院_骨科第一临床医学院（信息与工程学院）、附属第一医院_浙江省胰脏肝脏危重性疾病重点实验室
通讯作者	Chen, Lei; Kong, Hongru
作者单位	1.Department of Surgery,The First Affiliated Hospital of Wenzhou Medical University,Wenzhou, Zhejiang Province,China; 2.Key Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province,Zhejiang Provincial Top Key Discipline in Surgery,The First Affiliated Hospital of Wenzhou Medical University,Wenzhou, Zhejiang Province,China; 3.Department of Orthopaedics,The First Affiliated Hospital of Wenzhou Medical University,Wenzhou, Zhejiang Province,China
第一作者单位	附属第一医院; 第一临床医学院（信息与工程学院）、附属第一医院
通讯作者单位	附属第一医院; 第一临床医学院（信息与工程学院）、附属第一医院
第一作者的第一单位	附属第一医院
推荐引用方式 GB/T 7714	Ni, Xiaofeng,Li, Ding,Dai, Shengjie,et al. Development and Evaluation of Nomograms to Predict the Cancer-Specific Mortality and Overall Mortality of Patients with Hepatocellular Carcinoma[J]. BIOMED RESEARCH INTERNATIONAL,2021,2021:1658403.
APA	Ni, Xiaofeng., Li, Ding., Dai, Shengjie., Pan, Hao., Sun, Hongwei., ... & Kong, Hongru. (2021). Development and Evaluation of Nomograms to Predict the Cancer-Specific Mortality and Overall Mortality of Patients with Hepatocellular Carcinoma. BIOMED RESEARCH INTERNATIONAL, 2021, 1658403.
MLA	Ni, Xiaofeng,et al."Development and Evaluation of Nomograms to Predict the Cancer-Specific Mortality and Overall Mortality of Patients with Hepatocellular Carcinoma".BIOMED RESEARCH INTERNATIONAL 2021(2021):1658403.